262 related articles for article (PubMed ID: 28498607)
21. Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene.
Cieply B; Zeng G; Proverbs-Singh T; Geller DA; Monga SP
Hepatology; 2009 Mar; 49(3):821-31. PubMed ID: 19101982
[TBL] [Abstract][Full Text] [Related]
22. Tumor heterogeneity in small hepatocellular carcinoma: analysis of tumor cell proliferation, expression and mutation of p53 AND beta-catenin.
An FQ; Matsuda M; Fujii H; Tang RF; Amemiya H; Dai YM; Matsumoto Y
Int J Cancer; 2001 Aug; 93(4):468-74. PubMed ID: 11477549
[TBL] [Abstract][Full Text] [Related]
23. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
24. Four gene intrahepatic metastasis-risk signature predicts hepatocellular carcinoma malignant potential and early recurrence from intrahepatic metastasis.
Nakagawa S; Yamashita YI; Umezaki N; Yamao T; Kaida T; Hiyoshi Y; Mima K; Okabe H; Hayashi H; Imai K; Chikamoto A; Baba H
Surgery; 2021 Apr; 169(4):903-910. PubMed ID: 33160638
[TBL] [Abstract][Full Text] [Related]
25. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
[TBL] [Abstract][Full Text] [Related]
26. Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma.
Huang SF; Wu HD; Chen YT; Murthy SR; Chiu YT; Chang Y; Chang IC; Yang X; Loh YP
Tumour Biol; 2016 Jul; 37(7):9745-53. PubMed ID: 26803519
[TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.
Chen J; Liu J; Jin R; Shen J; Liang Y; Ma R; Lin H; Liang X; Yu H; Cai X
PLoS One; 2014; 9(11):e111885. PubMed ID: 25401330
[TBL] [Abstract][Full Text] [Related]
28. The Optimal Management for Sub-Centimeter Hepatocellular Carcinoma: Curative Treatments or Follow-Up?
Sun X; Zhang Y; Lyu N; Li X; Chen M; Zhao M
Med Sci Monit; 2019 Jul; 25():4941-4951. PubMed ID: 31270311
[TBL] [Abstract][Full Text] [Related]
29. Implication of microscopic and macroscopic vascular invasion for liver resection in patients with hepatocellular carcinoma.
Faber W; Stockmann M; Kruschke JE; Denecke T; Bahra M; Seehofer D
Dig Surg; 2014; 31(3):204-9. PubMed ID: 25196847
[TBL] [Abstract][Full Text] [Related]
30. Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.
Peng SY; Lai PL; Pan HW; Hsiao LP; Hsu HC
Oncol Rep; 2008 Apr; 19(4):1045-53. PubMed ID: 18357395
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic features of early hepatocellular carcinoma.
Yamasaki T; Kurokawa F; Kato A; Irie K; Yutoku K; Terai S; Matsuzaki Y; Yasunaga M; Okita K
Hepatogastroenterology; 1996; 43(10):926-31. PubMed ID: 8884315
[TBL] [Abstract][Full Text] [Related]
32. Three decades' experience in surgery of hepatocellular carcinoma.
Tang ZY; Yu YQ; Zhou XD; Yang BH; Lin ZY; Lu JZ; Ma ZC; Ye SL; Liu KD
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():126-33. PubMed ID: 9210895
[TBL] [Abstract][Full Text] [Related]
33. Dynamics and predicted drug response of a gene network linking dedifferentiation with beta-catenin dysfunction in hepatocellular carcinoma.
Gérard C; Di-Luoffo M; Gonay L; Caruso S; Couchy G; Loriot A; Castven D; Tao J; Konobrocka K; Cordi S; Monga SP; Hanert E; Marquardt JU; Zucman-Rossi J; Lemaigre FP
J Hepatol; 2019 Aug; 71(2):323-332. PubMed ID: 30953666
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
[TBL] [Abstract][Full Text] [Related]
35. Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma.
Ke AW; Shi GM; Zhou J; Wu FZ; Ding ZB; Hu MY; Xu Y; Song ZJ; Wang ZJ; Wu JC; Bai DS; Li JC; Liu KD; Fan J
Hepatology; 2009 Feb; 49(2):491-503. PubMed ID: 19065669
[TBL] [Abstract][Full Text] [Related]
36. High CD44s expression is associated with the EMT expression profile and intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy.
Mima K; Hayashi H; Imai K; Kuroki H; Nakagawa S; Okabe H; Chikamoto A; Watanabe M; Beppu T; Baba H
J Hepatobiliary Pancreat Sci; 2013 Apr; 20(4):429-34. PubMed ID: 23238743
[TBL] [Abstract][Full Text] [Related]
37. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
38. Local therapy improvement of outcome in a patient with recurrent hepatocellular carcinoma after living donor liver transplantation: a case report.
Shimokawa M; Itoh S; Ikegami T; Takeishi K; Harimoto N; Yamashita YI; Yoshizumi T; Kawanaka H; Shirabe K; Maehara Y
Anticancer Res; 2015 Jun; 35(6):3525-9. PubMed ID: 26026120
[TBL] [Abstract][Full Text] [Related]
39. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
40. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
